Ip Group Executive Interview Edison Group

Ip Group Executive Interview Edison Group In this interview, ip group ceo greg smith introduces the company and explains what differentiates its investment model and approach. he talks about the group’s international positioning and parkwalk, the group’s uk fund management business. Greg smith executive interview with edison october 2025.

Ip Group Executive Interview Edison Group In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront. Edison's dan ridsdale recently caught up with the company's ceo, greg smith, discussing the group’s performance and portfolio over the course of h1, the government’s ambition for the uk to. Edison advisors leverages our core research platform to provide differentiated services including investor relations, esg and strategic consulting. all interviews have been prepared and issued by edison for publication globally. In this interview, ip group’s ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in fy24 and what underpins the company's target of delivering a further £250m in exits between now and fye27.

Ip Group Executive Interview Edison Group Edison advisors leverages our core research platform to provide differentiated services including investor relations, esg and strategic consulting. all interviews have been prepared and issued by edison for publication globally. In this interview, ip group’s ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in fy24 and what underpins the company's target of delivering a further £250m in exits between now and fye27. In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront cash), whose met 097 anti obesity drug is progressing through phase ii. In this interview, ip group’s ceo, greg smith, discusses the company’s performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in fy24 and what underpins the company’s target of delivering a further £250m in exits between now and fye27. Ip group ceo greg smith discusses why he believes the uk has the potential to become a science superpower and the role ip group and the wider investment community needs to play to make this happen. Ip group helps to create, build and support ip based companies internationally. it focuses on companies that meaningfully contribute to regenerative (renewable), healthier (life sciences) and tech enriched (deep tech) futures.

Ip Group Executive Interview Edison Group In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront cash), whose met 097 anti obesity drug is progressing through phase ii. In this interview, ip group’s ceo, greg smith, discusses the company’s performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in fy24 and what underpins the company’s target of delivering a further £250m in exits between now and fye27. Ip group ceo greg smith discusses why he believes the uk has the potential to become a science superpower and the role ip group and the wider investment community needs to play to make this happen. Ip group helps to create, build and support ip based companies internationally. it focuses on companies that meaningfully contribute to regenerative (renewable), healthier (life sciences) and tech enriched (deep tech) futures.

Irlab Therapeutics Executive Interview Edison Group Ip group ceo greg smith discusses why he believes the uk has the potential to become a science superpower and the role ip group and the wider investment community needs to play to make this happen. Ip group helps to create, build and support ip based companies internationally. it focuses on companies that meaningfully contribute to regenerative (renewable), healthier (life sciences) and tech enriched (deep tech) futures.